Literature DB >> 7600379

Identification of profilin as an IgE-binding component in latex from Hevea brasiliensis: clinical implications.

P Vallier1, S Balland, R Harf, R Valenta, P Deviller.   

Abstract

Considering the high occurrence of profilin as an allergen in many plant species, the assumption was made that profilin might be an allergen in Hevea brasiliensis, a member of the latex producing Euphorbiaceae family. Using IgE-binding inhibition by purified profilins we demonstrated that profilin is an IgE-binding component in the cytosolic fraction of natural latex and, to a lower extent, in the rubber fraction. Thirty-five out of 36 sera containing IgE to ragweed-profilin reacted with profilin from latex, indicating structural homologies between profilins from latex and ragweed. A large percentage (59%) of these sera were found to be positive in CAP latex assay. The preincubation of these sera with purified ragweed profilin greatly inhibited the CAP latex. Because profilin is also present in banana extract, it is likely to be involved in cross-sensitivity to banana and latex. In a group of 19 individuals allergic to latex only two had anti-profilin IgE antibodies. Profilin was barely detectable on glove extract immunoblots, whereas some sera from patients allergic to latex reacted with a 15 kDa allergen which was not profilin. Consequently, IgE antibodies to latex-profilin is a questionable factor for sensitization of occupationally-exposed patients; however, sensitization to profilin should be taken into account when interpreting the results of latex IgE antibody assays.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7600379     DOI: 10.1111/j.1365-2222.1995.tb01051.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  10 in total

Review 1.  Cross-reactivity of plant and animal allergens.

Authors:  R W Weber
Journal:  Clin Rev Allergy Immunol       Date:  2001-10       Impact factor: 8.667

Review 2.  Natural rubber latex allergy.

Authors:  H Alenius; K Turjanmaa; T Palosuo
Journal:  Occup Environ Med       Date:  2002-06       Impact factor: 4.402

Review 3.  Cross-reactivity of pollen allergens.

Authors:  Richard W Weber
Journal:  Curr Allergy Asthma Rep       Date:  2004-09       Impact factor: 4.806

Review 4.  Allergic crossreactions. General and practical aspects.

Authors:  D A Vuitton
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

Review 5.  Crossreactions involving natural rubber latex.

Authors:  F Lavaud; D Sabouraud; F Deschamps; D Perdu
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

6.  Sequence homology: a poor predictive value for profilins cross-reactivity.

Authors:  Mojtaba Sankian; Abdolreza Varasteh; Nazanin Pazouki; Mahmoud Mahmoudi
Journal:  Clin Mol Allergy       Date:  2005-09-10

7.  Specific IgE response to purified and recombinant allergens in latex allergy.

Authors:  Viswanath P Kurup; Gordon L Sussman; Hoong Y Yeang; Nancy Elms; Heimo Breiteneder; Siti A M Arif; Kevin J Kelly; Naveen K Bansal; Jordan N Fink
Journal:  Clin Mol Allergy       Date:  2005-08-10

Review 8.  Molecular approach to a patient's tailored diagnosis of the oral allergy syndrome.

Authors:  Claudia Alessandri; Rosetta Ferrara; Maria Livia Bernardi; Danila Zennaro; Lisa Tuppo; Ivana Giangrieco; Teresa Ricciardi; Maurizio Tamburrini; Maria Antonietta Ciardiello; Adriano Mari
Journal:  Clin Transl Allergy       Date:  2020-06-17       Impact factor: 5.871

9.  Analysis of the effects of polymorphism on pollen profilin structural functionality and the generation of conformational, T- and B-cell epitopes.

Authors:  Jose C Jimenez-Lopez; María I Rodríguez-García; Juan D Alché
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

Review 10.  Allergen Immunotherapy (AIT): a prototype of Precision Medicine.

Authors:  G W Canonica; C Bachert; P Hellings; D Ryan; E Valovirta; M Wickman; O De Beaumont; J Bousquet
Journal:  World Allergy Organ J       Date:  2015-11-10       Impact factor: 4.084

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.